Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in New Hampshire?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A New Hampshire resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New Hampshire-licensed prescriber, including by telemedicine; RSA 329:1-d treats an out-of-state physician treating a New Hampshire patient by telemedicine as practicing medicine in New Hampshire, so a New Hampshire license is required. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy permitted by the New Hampshire Board of Pharmacy, part of the Office of Professional Licensure and Certification; out-of-state pharmacies need a New Hampshire mail-order (nonresident) pharmacy registration under RSA 318:37.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed
Compounded GLP-1
Limited

Can a New Hampshire resident get peptides by telehealth?

RSA 329:1-c defines the physician-patient relationship as a medical connection that includes an in-person exam or an exam using telemedicine as defined in RSA 310, provided the physician verifies the patient's identity, discloses the physician's name, contact information, and license type, obtains consent, and meets the standard of care. The physician must complete or review a history, a diagnosis, and a treatment plan, and prescribing without a physician-patient relationship is unprofessional conduct. RSA 310:7 and RSA 329:1-d define telemedicine to include synchronous or asynchronous interactions, and RSA 310:7 defines an asynchronous interaction as an exchange of information that does not occur in real time. An out-of-state physician treating a New Hampshire patient by telemedicine must be licensed in New Hampshire or practice under a licensing compact or endorsement, and telemedicine is held to the in-person standard of care. For Schedule II through IV controlled drugs, RSA 329:1-d requires a follow-up evaluation at least annually, but that rule does not apply to the non-controlled peptides in this database. The only express questionnaire bar covers eyeglass and contact lens prescriptions. This record classifies asynchronous prescribing as allowed because the statute lets the required exam be done by telemedicine and defines telemedicine to include asynchronous interactions. [2] [3] [4]

How does the New Hampshire pharmacy board treat compounding?

Compounding regulator for New Hampshire
BoardNew Hampshire Board of Pharmacy (Office of Professional Licensure and Certification)
Eligible substancesFollows the federal 503A framework

The Board of Pharmacy regulates pharmacists and pharmacies under RSA chapter 318 and adopts the Ph 100 through Ph 2600 rules. Part Ph 404 (Standards for compounding and dispensing sterile and non-sterile pharmaceuticals) applies to all non-sterile and sterile compounding, and Ph 404.01(b) requires every compounder to comply with the current edition of the United States Pharmacopeia, including USP chapters 795 and 797. RSA 318:37 and the surrounding mail-order pharmacy provisions require an out-of-state pharmacy that ships prescriptions to New Hampshire residents to register with the Board, and let the Board seek disciplinary records from the pharmacy's home state. New Hampshire has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [5] [6] [7] [8] [9]

Can you get compounded GLP-1s in New Hampshire?

Regulatory: Compounded GLP-1 limited

A telehealth GLP-1 program serving New Hampshire needs a New Hampshire-licensed prescriber under RSA 329:1-d and a pharmacy with a New Hampshire mail-order registration. [2] [6] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in New Hampshire?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in New Hampshire

What you'll actually find in New Hampshire, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [16] [17] [18]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [19]

What New Hampshire has done

PeptideAgent has not found a board or legislative action on peptides in New Hampshire.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [21] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [22] [23] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in New Hampshire. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] [4] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the New Hampshire Board of Pharmacy (Office of Professional Licensure and Certification); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [20]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [19]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [10] [24] [25]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [20] [26] [27]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [18] [27] [28]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [19] [29] [30] [31] [32] [33]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [19]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [20]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [18]
  • Pharmacy: Is this made for me on a prescription written in my name? [28]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [18] [27]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [18]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in New Hampshire?

RSA chapter 318 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners, so sellers of "research use only" injectable peptides to New Hampshire consumers are not lawful dispensers in the state. [5] [13]

Peptide-specific notes for New Hampshire

Peptide-specific notes for New Hampshire
PeptideNote
SemaglutideAvailable branded by prescription from a New Hampshire-licensed prescriber, including by telemedicine under RSA 329:1-c and RSA 310:7. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [3] [4] [12]

Frequently asked questions

Can I get a GLP-1 prescription in New Hampshire through telemedicine?

Yes, from a prescriber licensed in New Hampshire. RSA 329:1-c lets a physician form the physician-patient relationship through an exam using telemedicine, and RSA 310:7 defines telemedicine to include synchronous or asynchronous interactions. Semaglutide and tirzepatide are not controlled substances, so the follow-up evaluation rule for controlled drugs does not apply. [2] [3] [4]

Can an out-of-state doctor treat me in New Hampshire by telemedicine?

Only with a New Hampshire license, or under a licensing compact or endorsement as RSA 310:7 allows. RSA 329:1-d treats an out-of-state physician providing telemedicine to a New Hampshire patient as practicing medicine in the state, apart from narrow physician-to-physician consultation. [2] [4]

Can an out-of-state pharmacy ship compounded peptides to me in New Hampshire?

Only if it is registered with the New Hampshire Board of Pharmacy as a mail-order pharmacy under RSA 318:37 and the related provisions. Check the OPLC license lookup before ordering. [1] [6]

Can a New Hampshire pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: New Hampshire has no state bulks list; peptide eligibility follows the federal 503A framework. [9] [10] [11] [14] [15]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]New Hampshire Board of Pharmacy (OPLC)
  2. [2]New Hampshire RSA 329:1-d, Telemedicine
  3. [3]New Hampshire RSA 329:1-c, Physician-patient relationship
  4. [4]New Hampshire RSA 310:7, Telemedicine and telehealth services
  5. [5]New Hampshire RSA chapter 318, Pharmacists and pharmacies
  6. [6]New Hampshire RSA 318:37, Mail-order pharmacies: registration required; compliance
  7. [7]New Hampshire Board of Pharmacy laws and rules (Ph 100 to Ph 2600)
  8. [8]N.H. Code Admin. R. Ph 404, Standards for compounding and dispensing sterile and non-sterile pharmaceuticals (in Ph 100 to Ph 2600)
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in New Hampshire?. https://peptideagent.ai/legal/new-hampshire
HTML link
<a href="https://peptideagent.ai/legal/new-hampshire">Are peptides legal in New Hampshire?</a>, PeptideAgent, updated October 28, 2026.